{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"producer": "iLovePDF", "creator": "PDFMiner", "creationdate": "", "moddate": "2025-09-14T06:45:35+00:00", "total_pages": 280, "source": "./oasis_manual.pdf"}, "page_content": "\u2022  At Transfer - A subsequent provider is identified when the patient has transferred to any inpatient facility \n\n(M0100, RFA 6 or 7). \n\n\u2022  At Discharge \u2013 A subsequent provider is identified when the patient has been discharged from your agency \nand remained in a non-inpatient setting receiving skilled services from another Medicare-certified home \nhealth agency (M2420 response 2) or home hospice (M2420 response 3). \n\nOASIS-E1 \nEffective 01/01/2025 \nCenters for Medicare & Medicaid Services \n\n44\n\fChapter 3 \n\nSection A: Administrative Information \n\n\u2022  While the patient may receive care from other providers after discharge from your agency, such as primary \n\ncare providers, other outpatient providers, and residential treatment centers, these locations are not \nconsidered to be a subsequent provider for the purpose of coding this item. \n\n\u2022  Current Reconciled Medication list -This refers to a list of the patient\u2019s current medications at the time of \n\ndischarge that was reconciled by the agency prior to the patient\u2019s discharge. \n\n\u2022  Your agency should be guided by current standards of care and any applicable regulations and guidelines \n\n(e.g., Conditions of Participation) in determining what information should be included in a current reconciled \nmedication list. \n\nAdditional Considerations for Important Medication List Content", "type": "Document"}}